Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syn
ClinicalTrials.gov study NCT00988715. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04190550. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06969430. IPD Sharing: NO. Countries: 1. Publications: 0.
Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02029950. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant
ClinicalTrials.gov study NCT00469820. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05682170. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplas
ClinicalTrials.gov study NCT00008151. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02842112. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia.
ClinicalTrials.gov study NCT02450877. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02909972. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia
ClinicalTrials.gov study NCT00677859. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy
ClinicalTrials.gov study NCT06930352. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT05143996. IPD Sharing: NO. Countries: 1. Publications: 0.
CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03896854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05736965. IPD Sharing: NO. Countries: 1. Publications: 0.
Relation of C-reactive Protein/ Albumin Ratio and Coagulation Profile in Acute Myeloid Leukemia Patients
ClinicalTrials.gov study NCT06714071. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04964505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03473457. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
ClinicalTrials.gov study NCT06484062. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05241093. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.